Evidence map›Paper›PMID 29707396›Full record

ArticleCase reports in oncological medicine2018

Orbital Desmoid-Type Fibromatosis: A Case Report and Literature Review.

Alessandro Moro, Paolo De Angelis, Giulio Gasparini, Sandro Pelo, Gianluigi Petrone, Emanuela Lucci Cordisco, Umberto Garagiola, Giuseppe D'Amato, Gianmarco Saponaro

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in oncological medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 11 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alessandro MoroDepartment of Oral and Maxillofacial Surgery, Catholic University of the Sacred Heart Medical School, Rome, Italy.
Paolo De AngelisDepartment of Oral and Maxillofacial Surgery, Catholic University of the Sacred Heart Medical School, Rome, Italy.ORCID 0000-0002-0310-0037
Giulio GaspariniDepartment of Oral and Maxillofacial Surgery, Catholic University of the Sacred Heart Medical School, Rome, Italy.ORCID 0000-0001-5091-5178
Sandro PeloDepartment of Oral and Maxillofacial Surgery, Catholic University of the Sacred Heart Medical School, Rome, Italy.
Gianluigi PetroneDepartment of Histopathology and Cytopathology, Catholic University of the Sacred Heart Medical School, Rome, Italy.
Emanuela Lucci CordiscoDepartment of Genomic Medicine, Catholic University of the Sacred Heart Medical School, Rome, Italy.
Umberto GaragiolaDepartment of Orthodontics, University of Milan, Milan, Italy.ORCID 0000-0002-3256-6725
Giuseppe D'AmatoDepartment of Oral and Maxillofacial Surgery, Catholic University of the Sacred Heart Medical School, Rome, Italy.
Gianmarco SaponaroDepartment of Oral and Maxillofacial Surgery, Catholic University of the Sacred Heart Medical School, Rome, Italy.ORCID 0000-0001-9760-2419
Università Cattolica del Sacro Cuore · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDesmoid-type fibromatosis is a benign fibrous neoplasia originating from connective tissue, fascial planes, and musculoaponeurotic structures of the muscles. Currently, there is no evidence-based treatment approach available for desmoid fibromatosis. In this article, a case of a patient in the pediatric age affected by desmoid fibromatosis localized in the orbit is presented. The aim of the article is to describe this unusual and rare location for the desmoid fibromatosis and outline the principle phases in the decision-making process and the therapeutic alternatives for a patient affected by desmoid fibromatosis.

methodsThe protocol of this review included study objectives, search strategy, and selection criteria. The primary end point of this study was to analyze the head and neck desmoid fibromatosis. The secondary end point was to identify the available therapies and assess their specific indications.

resultsThe mean age of patients was 18.9 years ranging from 0 to 66, and 52% were female. A bimodal age distribution was observed, and two age peaks were identified: 0-14 years (57%) and 28-42 years (18%). The most common involved areas were the mandible (25%) followed by the neck (21%). In 86% of the cases, the treatment was the surgical resection of the disease, and only in 5% of the cases, the surgical resection was followed by adjuvant radiotherapy.

conclusionThe orbital location is extremely rare, especially in the pediatric population. The management of desmoid fibromatosis is based on the function preservation and the maintenance of a good quality of life, but in case of symptomatic patients or aggressive course of the disease or risk of functional damages, the surgical approach may be considered. Therapeutic alternatives to surgical resection are radiotherapy and systemic therapy.

Identifiers

PMID29707396
PMCPMC5863316
OpenAlexW2793676508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.